Skip to content

A C0MPARATIVE STUDY OF 8 LIMBED SHAPE AND DOTTED SHAPE OF INTENTIONAL SYSTEMATIC THERAPEUTIC BURN THERAPY WITH GOLD METALLIC INSTRUMENT IN THE MANAGEMENT OF PAIN AT THE BACK OF NECK AND RESTRICTED MOVEMENTS OF NECK.

â??A C0MPARATIVE STUDY OF ASHTAPADA AND BINDU TYPE OF AGNIKARMA WITH SUVARNA SHALAKA IN THE MANAGEMENT OF MANYASTAMBH W.S.R. TO CERVICAL SPONDYLOSISâ?? - NO

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033023
Enrollment
60
Registered
2021-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M488- Other specified spondylopathies Health Condition 2: M488- Other specified spondylopathies Health Condition 3: M478- Other spondylosis Health Condition 4: M478- Other spondylosis

Interventions

Intervention1: Ashtapada type of Agnikarma with Suvarna shalaka: Written informed consent from the patient will be taken. Goniometric measurements will be taken. Most painful sites will be marked. Ash

Sponsors

Dr Monika Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)60 Patients will be selected having sign and symptoms of Manyastambh b) Patients of either sex. c) Patients in age group of 21-60 years d) Willingness of patient

Exclusion criteria

Exclusion criteria: Patients below 21 years and above 60 years of age. Patients with a) Neoplastic cause b) Accidental case c) Infective pathology- HIV, Meningitis d) Neurological complications e) Rheumatoid Arthritis f)Avabahuk, Vishvachi g)UncontrolledHypertension,Diabetesmellitus,Cardiac disorders,Migraine, Anemia. h) Non co-operative patients i) Pregnant patients as they are contraindicated for Agnikarma

Design outcomes

Primary

MeasureTime frame
Reduction in pain and stiffness of neck. Timepoint: 1/2/3/4/5/6/7/10/21days.

Secondary

MeasureTime frame
Increase in range of motionTimepoint: Rate of clinical cure at day 1/2/3/4/5/6/7/10/21

Countries

India

Contacts

Public ContactDr Monika Gupta

Shri Krishna Government Ayurvedic College Kurukshetra

drmonikagupta88@gmail.com9050943299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026